An Update on the Diagnosis and Management of Calcium Crystal Disease

Curr Rheumatol Rep. 2023 Aug;25(8):145-151. doi: 10.1007/s11926-023-01106-9. Epub 2023 May 30.

Abstract

Purpose of review: This article aims to review the challenges to diagnosis and management of calcium crystal deposition diseases and evaluate the literature published over the past 3 years.

Recent findings: The awaited development of classification criteria is an essential step in the progression of calcium crystal deposition disease clinical research. There have been recent improvements in the accuracy of imaging for the diagnosis of crystal deposition diseases with published definitions of characteristic features. Factors associated with acute flares of disease have been identified and an association with increased cardiovascular risk has been demonstrated. Targeted treatment options for calcium crystal diseases remain elusive. However, there have been advances in understanding the molecular mechanisms of disease revealing potential targets for future drug development. Calcium-crystal deposition diseases are increasing in incidence and prevalence as populations age and continue to associate with a high burden of disability. Despite this, calcium crystal deposition disease remains under-studied with a paucity of evidence-based treatment guidelines.

Keywords: BCP Crystals; CPPD; Calcium Crystal Disease; Calcium Crystals; Crystal Arthritis; Pseudogout.

Publication types

  • Review

MeSH terms

  • Calcium / therapeutic use
  • Calcium Pyrophosphate
  • Chondrocalcinosis*
  • Humans

Substances

  • Calcium
  • Calcium Pyrophosphate